Zhejiang Jolly Pharmaceutical Co.,LTD engages in the research, production, and marketing of Chinese medicinal products in the People’s Republic of China and int...
Jolly Pharmaceuticals released its performance for the first three quarters, with a net profit attributable to the parent company of 510 million yuan, an increase of 21.00%
Shandong Weida Machinery And 2 Other Asian Small Caps with Promising Potential
Jolly: The digital workshop for solid pharmaceutical preparations is expected to be operational by the end of the year
Jolly: The research and development work on the Parkinson's pipeline LY-N001 of Lingyi Biotech is ongoing
Jolly released its performance for the first half of the year, with a net profit attributable to the parent company of 374 million yuan, an increase of 26.16%
Jolly will jointly establish a Smart Empowerment Food and Drug Research and Development Center with Zhejiang University